Global Weight Loss and Obesity Management Market Size, Trends & Growth Opportunity, By Diet (Meals, Beverages, and Supplements), By Equipment (Fitness Equipment, and Surgical Equipment), By Services, By Region and Forecast from 2022-2027.
Global Weight Loss and Obesity Management Market
Global Weight Loss and Obesity Management Market was valued at USD 180.12 million in 2021 which expected to reach USD 415.28 million by 2027 at a CAGR 6.45%.
A chronic medical disease known as obesity is characterized by an excessive buildup and storage of body fat. Body Mass Index is used to calculate it (BMI). Drugs, nutritional supplements, weight reduction surgery, and exercise are some of the ways utilized to treat weight loss and obesity. According to data from the World Health Organization (WHO), an individual is considered overweight when their Body Mass Index (BMI) is 25 or higher, and they are considered obese when their BMI is 30 or higher.
Market Drivers
The main causes of obesity include an increase in disposable income, a rise in the consumption of high-calorie fast food, as well as a rise in the acceptance of unhealthy lifestyles as a result of the expansion of the fast-food industry. The increased demand for weight loss and obesity treatment as a result is what fuels the market's expansion. The measures taken by the government and for-profit and nonprofit organizations to improve population diet and physical activity habits at the local, regional, and global levels are also boosting the growth of the worldwide weight loss and obesity management market.
Additionally, due to the rise in COVID-19 outbreaks, 88% of businesses now allow employees to work from home. As a result, there has been a significant decline in people's physical activity, which has led to weight gain and other problems. These factors are anticipated to drive the growth of the global weight loss and obesity management market over the course of the forecast period.
The market for managing obesity and weight reduction is anticipated to develop as a result of key players adopting more techniques. For instance, a Phase IIIa trial conducted by Novo Nordisk in May 2021 revealed that semaglutide, a weight-loss medicine, can enhance physical function and wellbeing in obese individuals.
Market Restraints
The main barrier to the expansion of the global weight loss and obesity management market is projected to be product recall. For instance, the Food and Drug Administration withdrew Lipodrene w/25mg Ephedra Extract Dietary Supplement in May 2021 because it contained the banned component (DMAA), which can lead to significant issues like shortness of breath, high blood pressure, arrhythmias, and heart attacks.
Market Segmentation
The Global Weight Loss and Obesity Management Market is segmented into diet such as Meals, Beverages, and Supplements. Diet is gaining popularity for weigh loss management in developed and in developing countries. Meals comprises the good number of fibers, proteins, and lesser amount of carbohydrates are considered as an effective weight management method. Further, market is segmented into Fitness Equipment, and Surgical Equipment. The Fitness equipment is expected to hold largest share of the market. On the basis of services market is segmented into Fitness Centers, Sliming centers, Consultation services, and Online weight loss services.
Regional Analysis
The Global Weight Loss and Obesity Management Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Due to the rising prevalence of overweight people as well as hypertension and diabetes, the North American region will hold the greatest market share in 2020. Over the projection period, it is anticipated that the APAC region would experience the quickest increase. Diet plan popularity will considerably contribute to the growth of the global weight loss and obesity management market as people become more aware of other options for weight loss and control.
Key Players
Some of the key players competing in this industry such as Novo Nordisk A/S, Herbalife Ltd., Takeda Pharmaceutical, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., NutriSystem, Inc., Cybex International, Ethicon Inc., Johnson & Johnson Services, Inc, Medtronic,etc.
Market Taxonomy
By Diet
By Equipment
By Services
By Region
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook